sec filing
RL
NASDAQ · RLMD
Relmada Therapeutics, Inc.
Healthcare · Biotechnology
$4.22
Down-$0.22 (-4.95%)
Updated Sep 17, 2026, 6:27 AM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 309.47M
- P/E ratio
- -2.07
- Dividend yield
- 0.00%
- 52-week range
- $4.00 – $8.00
- Volume
- 824.38K
- Avg. volume
- 1.02M
Price performance
RLMD price history
1M range · 0 trading sessions · Daily adjusted prices
RLMD does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest RLMD news
The latest Smart Investors Daily articles mentioning RLMD.
Stock researchResearch & News · SEC Filings
Loading stock research…